PROTEIN-BINDING OF PHENYTOIN AND LIDOCAINE IN PEDIATRIC-PATIENTS WITH TYPE-I DIABETES-MELLITUS

被引:17
作者
KEARNS, GL
KEMP, SF
TURLEY, CP
NELSON, DL
机构
[1] UNIV ARKANSAS MED SCI,DEPT PEDIAT,LITTLE ROCK,AR 72205
[2] UNIV ARKANSAS MED SCI,DEPT BIOCHEM,LITTLE ROCK,AR 72205
[3] ARKANSAS CHILDRENS HOSP,DIV CRIT CARE MED,LITTLE ROCK,AR 72202
[4] ARKANSAS CHILDRENS HOSP,DIV ENDOCRINOL,LITTLE ROCK,AR 72202
[5] ARKANSAS CHILDRENS HOSP,DIV LAB MED,LITTLE ROCK,AR 72202
来源
DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS | 1988年 / 11卷 / 01期
关键词
D O I
10.1159/000457659
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:14 / 23
页数:10
相关论文
共 44 条
[1]  
ALBANI M, 1983, ANTIEPILEPTIC DRUG T
[2]   EVALUATION OF AN ULTRAFILTRATION FLUORESCENCE POLARIZATION IMMUNOASSAY FOR MONITORING UNBOUND PHENYTOIN [J].
ARGYLE, JC ;
KINNIBURGH, DW ;
COSTA, R ;
JENNISON, T .
THERAPEUTIC DRUG MONITORING, 1984, 6 (01) :117-120
[3]   MONITORING PHENYTOIN IN SALIVARY AND PLASMA ULTRAFILTRATES OF PEDIATRIC-PATIENTS [J].
BACHMANN, K ;
FORNEY, RB ;
VOELLER, K .
THERAPEUTIC DRUG MONITORING, 1983, 5 (03) :325-329
[4]  
BATSON HC, 1956, INTRO STATISTICS MED
[5]  
BIENVENU J, 1981, CLIN CHEM, V27, P721
[6]  
BOTTORFF MB, 1986, DRUG INTEL CLIN PHAR, V20, P463
[7]   NONENZYMATIC GLYCOSYLATION AND THE PATHOGENESIS OF DIABETIC COMPLICATIONS [J].
BROWNLEE, M ;
VLASSARA, H ;
CERAMI, A .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (04) :527-537
[8]   EFFECTS OF CARBAMYLATION OF PLASMA-PROTEINS AND COMPETITIVE DISPLACERS ON DRUG-BINDING IN UREMIA [J].
CALVO, R ;
CARLOS, R ;
ERILL, S .
PHARMACOLOGY, 1982, 24 (04) :248-252
[9]  
DAY JF, 1979, J BIOL CHEM, V254, P595
[10]  
DIXON WJ, 1969, INTRO STATISTICAL AN